rAAV-Olig001-ASPA Gene Therapy for Treatment of Children With Typical Canavan Disease
Clinical trial NCT04833907 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT04833907
- Sponsor
- Myrtelle Inc.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2026-08-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.